Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Gastrointestinal 4CNS 4Dermatologic 3Thoracic 2Sarcoma 2Genitourinary 2Breast 2Other solid neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Breast Neoplasms 2Melanoma 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 485Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 151Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
lentiviral minigene vaccine of COVID-19 coronavirus × Breast × Clear all
NCT00978913 2015-08-19

Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma

Herlev Hospital

Phase 1 Completed
31 enrolled
BreastDermatologic

Breast Neoplasms, Melanoma

NCT00935558 2012-05-31

Dendritic Cell Based Therapy for Breast Cancer Patients

Herlev Hospital

Phase 2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡